<![CDATA[How Is AI Already Being Used in Blood Cancer Tumor Boards?]]>

Summary

Matthew Matasar, MD, discussed the use of retrieval-augmented generation AI tools in informing tumor board decisions for hematologic malignancies. The article presents a general educational overview of AI applications in blood cancer clinical practice.